No registrations found.
ID
Source
Brief title
Health condition
Patients with osteoarthritis initiated for knee arthroplasty
Sponsors and support
Intervention
Outcome measures
Primary outcome
Health-Related Quality of Life
Secondary outcome
other PROMs:
Oxford Knee Score (OKS; 12 to 60, 12 being the best outcome) [Haverkamp et al. 2005] and the Western Ontario and McMaster Universities Arthritis Index (WOMAC; 0 to 100, 100 being the best outcome) [Roorda et al. 2004]. Experienced pain was measured by a Numerical Rating Scale (NRS, 0 to 10, 10 being ‘worst pain’).
Background summary
Modification of a selected number of literature-based protocols, used together, can be implemented in a care pathway. Such optimization is also known as ‘outpatient joint arthroplasty’, a multimodal clinical pathway based on well-defined patient selection criteria.
With the present case-controlled study, we want to analyze if the OS pathway will result in comparable or better outcomes compared to our standard pathway (ERP) if it becomes to Health-Related Quality of Life as measured with the EQ-5D PROMs.
Study objective
It was hypothesized that there would be no difference in quality of life between both pathways.
Study design
preoperative, 3- and 12-months postoperative
Intervention
enhanced recovery pathway
outpatient joint arthroplasty
M.G.M. Schotanus
Geleen 6162 BG
The Netherlands
+31 (0)88 4597823
m.schotanus@zuyderland.nl
M.G.M. Schotanus
Geleen 6162 BG
The Netherlands
+31 (0)88 4597823
m.schotanus@zuyderland.nl
Inclusion criteria
o Operated between June 2014 and June 2015
o Elective primary knee arthroplasty
Exclusion criteria
o Incomplete registration of data
o Acute or revision arthroplasty surgery
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL6248 |
| NTR-old | NTR6406 |
| Other | NA : 16N194 METC |
Summary results
Martijn G. M. Schotanus, Yoeri F. L. Bemelmans and Nanne P. Kort
J Clin Trials 2017, 7:5. DOI: 10.4172/2167-0870.1000327